Scott A. Peslak

Hematology

3400 Civic Center Boulevard
South Pavilion, 1st Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Beyond Hypersplenism: Splenic Marginal Zone Lymphoma in an Older Adult with Hemoglobin E/Beta-Thalassemia.

Beyond Hypersplenism: Splenic Marginal Zone Lymphoma in an Older Adult with Hemoglobin E/Beta-Thalassemia.

Journal: Hemoglobin

Published: May 13, 2026

Distribution of Gastrointestinal and Dietary Risk Factors Among U.S. Adults Classified as Having Iron Deficiency Anemia Across Diagnostic Thresholds.

Distribution of Gastrointestinal and Dietary Risk Factors Among U.S. Adults Classified as Having Iron Deficiency Anemia Across Diagnostic Thresholds.

Journal: American journal of hematology

Published: April 06, 2026

Delayed Recognition and Significant Morbidity in Adults with Non-Transfusion-Dependent Thalassemia.

Delayed Recognition and Significant Morbidity in Adults with Non-Transfusion-Dependent Thalassemia.

Journal: Blood advances

Published: February 17, 2026

Inflammation's Impact on Ferritin in Iron Deficiency-Reply.

Inflammation's Impact on Ferritin in Iron Deficiency-Reply.

Journal: JAMA internal medicine

Published: January 05, 2026

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Journal: Blood advances

Published: December 19, 2025

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.

Journal: Blood advances

Published: December 19, 2025

Diagnostic Serum Ferritin Thresholds and Prevalence of Iron Deficiency Anemia.

Diagnostic Serum Ferritin Thresholds and Prevalence of Iron Deficiency Anemia.

Journal: JAMA internal medicine

Published: August 25, 2025

Optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing.

Optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing.

Journal: Blood

Published: May 28, 2025

An optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing.

An optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing.

Journal: Blood

Published: May 28, 2025

Expansion of human hematopoietic stem cells by inhibiting translation.

Expansion of human hematopoietic stem cells by inhibiting translation.

Journal: bioRxiv : the preprint server for biology

Published: December 11, 2023

let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching.

let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching.

Journal: Blood

Published: November 27, 2023

Author Correction: HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription.

Author Correction: HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription.

Journal: Nature genetics

Published: July 31, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026